|
Volumn 43, Issue 1107, 2001, Pages 53-54
|
Galantamine (Reminyl) for Alzheimer's disease
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DONEPEZIL;
GALANTAMINE;
RIVASTIGMINE;
SABELUZOLE;
TACRINE;
ALZHEIMER DISEASE;
CLINICAL TRIAL;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
GASTROINTESTINAL SYMPTOM;
HUMAN;
SHORT SURVEY;
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
COGNITION;
DIARRHEA;
DIZZINESS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GALANTAMINE;
HUMANS;
NAUSEA;
VOMITING;
|
EID: 0035948004
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (5)
|
References (0)
|